Staging of colorectal cancer using lipid biomarkers and machine learning
Open Access
- 20 September 2023
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 19 (10) , 1-11
Abstract
Introduction: Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. Alteration in lipid metabolism and chemokine expression are considered hallmark characteristics of malignant progression and metastasis of CRC. Validated diagnostic and prognostic biomarkers are urgently needed to define molecular heterogeneous CRC clinical stages and subtypes, as liver dominant metastasis has poor survival outcomes. Objectives: The aim of this study was to integrate lipid changes, concentrations of chemokines, such as platelet factor 4 and interleukin 8, and gene marker status measured in plasma samples, with clinical features from patients at different CRC stages or who had progressed to stage-IV colorectal liver metastasis (CLM). Methods: High-resolution liquid chromatography-mass spectrometry (HR-LC-MS) was used to determine the levels of candidate lipid biomarkers in each CRC patient’s preoperative plasma samples and combined with chemokine, gene and clinical data. Machine learning models were then trained using known clinical outcomes to select biomarker combinations that best classify CRC stage and group. Results: Bayesian neural net and multilinear regression-machine learning identified candidate biomarkers that classify CRC (stages I-III), CLM patients and control subjects (cancer-free or patients with polyps/diverticulitis), showing that integrating specific lipid signatures and chemokines (platelet factor-4 and interluken-8; IL-8) can improve prognostic accuracy. Gene marker status could contribute to disease prediction, but requires ubiquitous testing in clinical cohorts. Conclusion: Our findings demonstrate that correlating multiple disease related features with lipid changes could improve CRC prognosis. The identified signatures could be used as reference biomarkers to predict CRC prognosis and classify stages, and monitor therapeutic intervention.Keywords
Funding Information
- Commonwealth Scientific and Industrial Research Organisation
This publication has 39 references indexed in Scilit:
- Metabonomics Identifies Serum Metabolite Markers of Colorectal CancerJournal of Proteome Research, 2013
- Plasma choline-containing phospholipids: potential biomarkers for colorectal cancer progressionMetabolomics, 2012
- IDEOM: an Excel interface for analysis of LC–MS-based metabolomics dataBioinformatics, 2012
- An Optimal Self‐Pruning Neural Network and Nonlinear Descriptor Selection in QSARQSAR & Combinatorial Science, 2009
- Optimal Sparse Descriptor Selection for QSAR Using Bayesian MethodsQSAR & Combinatorial Science, 2009
- Dealing with missing values and outliers in principal component analysisTalanta, 2007
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Changes in electric charge and phospholipids composition in human colorectal cancer cellsMolecular and Cellular Biochemistry, 2005
- Serum Lipid Profile in Colorectal Cancer Patients with and without Synchronous Distant MetastasesOncology, 2005
- Robust QSAR Models Using Bayesian Regularized Neural NetworksJournal of Medicinal Chemistry, 1999